• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Henry Schein buys majority of Prism Medical Products

Henry Schein buys majority of Prism Medical Products

January 6, 2021 By Sean Whooley

Henry Schein (NSDQ:HSIC) announced that it acquired a majority ownership position in home medical supply maker Prism Medical Products.

Elkin, N.C.-based Prism provides specialty home medical supplies with a core competency in advanced wound care products, according to a news release. The transaction leads Henry Schein Medical to enter an established and growing market for such products.

Prism will operate as a subsidiary of Henry Schein Medical and will be managed separately as an individual division by founder & president Chris Cartwright. The company has more than 200 team members and collected net revenue for the 12 months ended Sept. 30, 2020, of about $52 million.

“I am very proud of all that the team at Prism has accomplished, including our track record of organic revenue growth along with consistent increases in unique referral sources and new patients,” Cartwright said in the release. “We look to the future with excitement and optimism as part of Henry Schein Medical.

Melville, N.Y.-based Henry Schein expects Prism to be neutral to its 2021 earnings per diluted share and accretive thereafter, with further financial terms remaining undisclosed.

“Expanding beyond our core base of office-based physicians and entering the home health market has been a long-standing strategic goal of Henry Schein’s medical business, and with Prism we have the ideal partner with a strong brand and a complementary business model,” Henry Schein chairman & CEO Stanley M. Bergman said. “This partnership expands Henry Schein Medical’s continuum-of-care delivery model and allows us to move closer and to interact directly with patients. It also strengthens our relationships with the physicians who prescribe home medical supplies.

“Importantly, Prism and its management team is tightly aligned with Henry Schein’s strategy and culture, and we look forward to a smooth integration of this business. We welcome our new colleagues to Team Schein and look forward to continued success together.”

Filed Under: Business/Financial News, Dental, Featured, Mergers & Acquisitions, Wound Care Tagged With: Henry Schein Inc., Henry Schein Medical, Prism Medical

More recent news

  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform
  • MiniMed completes split from Medtronic
  • GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy